Avoro Life Sciences Fund LLC — Form D/A

Avoro Life Sciences Fund LLC of NEW YORK, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2026-05-01. $3.5B was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (18)

NameRoleLocation
Behzad AghazadehRelated PersonNew York, NY
Neil CammarosanoRelated PersonNew York, NY
Scott EpsteinRelated PersonNew York, NY
Kurt von EmsterExecutive OfficerRedwood City, CA
Kurt von EmsterPromoterRedwood City, CA
Behzad AghazadehExecutive OfficerNew York, NY
Scott EpsteinExecutive OfficerNew York, NY
- Avoro Capital L.P.PromoterNew York, NY
- Avoro Capital GP, LLCPromoterNew York, NY
- Avoro Capital Advisors LLCPromoterNew York, NY
Neil CammarosanoExecutive OfficerNew York, NY
Corey GoodmanExecutive OfficerCambridge, MA
Robert AdelmanExecutive OfficerSan Francisco, CA
N/A venBio Select Advisor LLCPromoterNew York, NY
N/A venBio Select Advisor Management Holdings GP, LLCPromoterNew York, NY
N/A venBio Select Advisor L.P.PromoterNew York, NY
LLC venBio Select AdvisorPromoterSan Francisco, CA
Paul BrookeExecutive OfficerSan Francisco, CA

Other filings by this issuer (16)

Showing 15 of 16 filings.

FiledFormOfferingSold
2025-05-02D/A$3.3B
2024-05-02D/A$3.2B
2023-05-02D/A$2.8B
2022-05-02D/A$2.5B
2021-05-03D/A$2.0B
2020-05-06D/A$1.7B
2019-05-22D/A$1.3B
2018-09-07D/A$1.2B
2017-10-11D/A$629.9M
2016-10-11D/A$412.9M
2015-10-09D/A$292.6M
2014-10-17D/A$124.0M
2013-10-21D/A$37.6M
2012-10-18D/A$21.8M
2011-08-01D/A$15.5M

More